All Wel-bioAps enzymes are generated from recombinant stock, which gives us much more control over the production processes. Similarly, we carefully select background strains, which helps us to eliminate non-specific endo- and exonuclease activity. Recombinant technology consistently generates a higher yield of purer product at a much lower cost, which lets us pass increased savings on to the customer.
